Search

everythinglearnresearchcommunity

for

Search:↓

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

People with alopecia areata may have a higher risk of blood clots.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Fat stem cells from diabetic mice can help heal skin wounds in other diabetic mice.

Some stem cells in the body rarely divide, which could help create better treatments for diseases and aging.

Home-use lasers and IPL devices are unlikely to directly cause paradoxical hair growth; it may be linked to inflammation or hormonal issues.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

New regenerative treatments for hair loss show promise but need more research for confirmation.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Plant adaptogens may help treat skin diseases and improve skin health, but more research is needed to fully understand how they work.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Biotin supplements are unnecessary for most people but may help with certain conditions like biotin deficiency, brittle nails, and some hair loss.

There's a growing resistance to the antibiotic mupirocin in children's skin infections caused by MRSA in New York.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Watching, not removing, skin growths with moderate atypia and positive edges is okay; patients may get melanoma elsewhere, especially if they've had it before.